Literature DB >> 6850843

Induction of macrophage-mediated cytolysis of neoplastic cells by mycoplasmas.

J Loewenstein, S Rottem, R Gallily.   

Abstract

Unexpected cytolysis was encountered when nonactivated murine peritoneal macrophages were cultured with [3H]TdR-prelabeled syngeneic or allogeneic tumor cells at a 10:1 ratio. The level of specific cytolysis reached 70% within 48 hr of cocultivation. Similar killing was observed whether the macrophages were derived from untreated, thioglycollate-treated, or germ-free mice. Cytolytic activity was also demonstrated when bone marrow-derived or peritoneal macrophages from 9- and 5-day in vitro cultures, respectively, were employed rather than freshly harvested peritoneal macrophages. Thus, the macrophage-mediated killing was neither the result of in vivo preactivation nor a consequence of the presence of lymphocytes in the assay. Moreover, macrophages derived from different strains caused similar effects. Our study revealed that the neoplastic target cell cultures susceptible to cytolysis by nonactivated macrophages were contaminated with mycoplasma. A mycoplasma was isolated from the supernatant of a culture of the A9HT fibrosarcoma line, identified as Mycoplasma orale, and cultivated. Addition of viable mycoplasma from that isolate to mixed cultures of thioglycollate-elicited macrophages and [3H]TdR-prelabeled mycoplasma-free target cells resulted in specific cytolysis of transformed A9 cells, but not of normal mouse fibroblasts. The level of macrophage-dependent cytolysis correlated with the number of viable mycoplasma cells added and was higher than that attained by activation with LPS at optimal concentration. Similar specific cytolysis was observed with heat-killed mycoplasmas. Our results demonstrate that mycoplasmas may cause selective macrophage-mediated cytolysis of neoplastic but not of normal target cells, perhaps via activation of the macrophages. It is suggested that undetected infection of experimental systems by mycoplasmas may account for some reports on lysis of neoplastic cells by nonactivated macrophages.

Entities:  

Mesh:

Year:  1983        PMID: 6850843     DOI: 10.1016/0008-8749(83)90029-1

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  10 in total

1.  Enhancing antitumor immunity perioperatively: a matter of timing, cooperation, and specificity.

Authors:  Jeffrey L Curtis; Antonello Punturieri
Journal:  Am J Respir Cell Mol Biol       Date:  2003-05       Impact factor: 6.914

2.  Suppression of both macrophage-mediated tumor cell lysis and cytolytic factor production by a factor (CIF) derived from normal embryonic fibroblasts.

Authors:  R Gallily; G E Gifford; J Loewenstein
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

3.  Effect of MALP-2, a lipopeptide from Mycoplasma fermentans, on bone resorption in vitro.

Authors:  G Piec; J Mirkovitch; S Palacio; P F Mühlradt; R Felix
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

4.  Induction of antitumor activity in macrophages by mycoplasmas in concert with interferon.

Authors:  K Uno; M Takema; S Hidaka; R Tanaka; T Konishi; T Kato; S Nakamura; S Muramatsu
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

Review 5.  Molecular biology and pathogenicity of mycoplasmas.

Authors:  S Razin; D Yogev; Y Naot
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

6.  Characterization and purification of a mycoplasma membrane-derived macrophage-activating factor.

Authors:  S Caplan; R Gallily; Y Barenholz
Journal:  Cancer Immunol Immunother       Date:  1994-07       Impact factor: 6.968

7.  Thymus-derived macrophages in long-term culture: release of IL-1, stimulation of MLR and expression of tumoricidal activity.

Authors:  R Gallily; M Zeira; I Stain
Journal:  Immunology       Date:  1985-05       Impact factor: 7.397

8.  Mycoplasma capricolum membranes induce tumor necrosis factor alpha by a mechanism different from that of lipopolysaccharide.

Authors:  T Sher; S Rottem; R Gallily
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

9.  Structure and specific activity of macrophage-stimulating lipopeptides from Mycoplasma hyorhinis.

Authors:  P F Mühlradt; M Kiess; H Meyer; R Süssmuth; G Jung
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

10.  Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration.

Authors:  P F Mühlradt; M Kiess; H Meyer; R Süssmuth; G Jung
Journal:  J Exp Med       Date:  1997-06-02       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.